サイクロトロンの世界市場：2023-2030年

サイクロトロンの世界市場は、予測期間（2023-2030年）にCAGR 11.2%で成長すると予測されています。市場成長の要因は、がんの有病率の増加や画像診断手順の使用の増加などです。世界保健機関（WHO）によると、がんは世界中で主要な死因となっており、2020年には約1,000万人、つまり死亡者の約6人に1人ががんで死亡しています。2020年に新たに発生するがんとしては、乳がん（226万件）、肺がん（221万件）、結腸・直腸がん（193万件）などがあります。加工肉の摂取が多く果物や野菜の摂取が少ない、座りっぱなしの生活、肥満、喫煙、過度のアルコール摂取など、いくつかの生活習慣要因ががんの発症に寄与しています。

セグメント別展望

医療用サブセグメントがサイクロトロンの世界市場でかなりのシェアを占めると予想される

用途別では、医療用サブセグメントは世界のサイクロトロン市場でかなりのシェアを占めると予想されます。このセグメントの成長は、陽電子放射断層撮影法（PET）のような様々な医療用画像技術における放射性医薬品製造における使用の増加、および正確な疾患診断のための核医学処置における需要の増加に起因しています。核医学検査は、様々な病状の検出やモニタリングに不可欠です。世界核医学会によると、核医学による手術は世界で毎年約4,000万件行われており、年間成長率は5.0％です。世界で10,000以上の病院が医療に放射性同位元素を使用しており、その約90％は診断のためのものです。診断に使用される最も一般的な放射性同位元素はテクネチウム-99（Tc-99m）であり、世界中の核医学手術の約80％、核医学診断スキャンの85％を占めています。

地域別展望

世界のサイクロトロン市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに区分されます。なかでもアジア太平洋地域は、予測期間中に最も高いCAGRを示すと予測されています。医療技術の進歩、可処分所得の増加、新興国における医療インフラの改善がアジア太平洋地域のサイクロトロン市場を牽引しています。

北米がサイクロトロンの世界市場で大きなシェアを占める

がん罹患率の上昇、有利な政府イニシアティブ、高度に発達した医療インフラがこの地域市場を牽引する主な要因です。米国がん協会の「Cancer Facts &Figures 2022」によると、米国では2022年に約1,918,030人が新たにがんに罹患し、609,360人ががんで死亡すると推定されています。この地域におけるこのようながんの高い発生率は、がんの診断のためのサイクロトロンの採用を増加させ、この地域の市場成長を促進すると予想されます。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Advanced Cyclotron Systems, Inc
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• GE HealthCare Technologies Inc.
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Ion Beam Applications SA（IBA）
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Siemens Medical Solutions USA, Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• サイクロトロンの世界市場：製品別
  • サイクロトロン10～12MeV
  • サイクロトロン16～18MeV
  • サイクロトロン19～24MeV
  • サイクロトロン24MeV以上
• サイクロトロンの世界市場：用途別
  • 医療用
  • 産業用

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• Alcen
• Best Cyclotron Systems, Inc.
• Covidien plc
• Cyclotron Inc.
• IONETIX Corp.
• Isosolution Inc.
• Nueclear Healthcare Ltd.
• Samsung Medical
• Stryker Corp.
• Sumitomo Heavy Industries, Ltd.
• TeamBest
• Varian Medical Systems, Inc.

LIST OF TABLES

• 1. GLOBAL CYCLOTRON MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 2. GLOBAL CYCLOTRON 10-12MEV MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 3. GLOBAL CYCLOTRON 16-18MEV MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 4. GLOBAL CYCLOTRON 19-24MEV MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 5. GLOBAL CYCLOTRON ABOVE 24MEVMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 6. GLOBAL CYCLOTRON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
• 7. GLOBAL CYCLOTRON FORMEDICALMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 8. GLOBAL CYCLOTRONFORINDUSTRIALMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 9. GLOBAL CYCLOTRON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 10. NORTH AMERICAN CYCLOTRON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 11. NORTH AMERICAN CYCLOTRON MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 12. NORTH AMERICAN CYCLOTRON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
• 13. EUROPEAN CYCLOTRON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 14. EUROPEAN CYCLOTRON MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 15. EUROPEAN CYCLOTRON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
• 16. ASIA-PACIFIC CYCLOTRON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 17. ASIA-PACIFIC CYCLOTRON MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 18. ASIA-PACIFIC CYCLOTRON MARKET RESEARCH AND ANALYSIS BY APPLICATION,2023-2031 ($ MILLION)
• 19. REST OF THE WORLD CYCLOTRON MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 20. REST OF THE WORLD CYCLOTRON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL CYCLOTRON MARKET SHARE BY PRODUCT, 2023 VS 2031 (%)
• 2. GLOBAL CYCLOTRON 10-12MEVMARKET SHARE BY REGION, 2023 VS 2031 (%)
• 3. GLOBAL CYCLOTRON 16-18MEV MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 4. GLOBAL CYCLOTRON 19-24MEVMARKET SHARE BY REGION, 2023 VS 2031 (%)
• 5. GLOBAL CYCLOTRON ABOVE 24MEVMARKET SHARE BY REGION, 2023 VS 2031 (%)
• 6. GLOBAL CYCLOTRON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023 VS 2031 (%)
• 7. GLOBAL CYCLOTRON FOR MEDICALMARKET SHARE BY REGION, 2023 VS 2031 (%)
• 8. GLOBAL CYCLOTRON FOR INDUSTRIALMARKET SHARE BY REGION, 2023 VS 2031 (%)
• 9. GLOBAL CYCLOTRON MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 10. US CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 11. CANADA CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 12. UK CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 13. FRANCE CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 14. GERMANY CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 15. ITALY CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 16. SPAIN CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 17. REST OF EUROPE CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 18. INDIA CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 19. CHINA CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 20. JAPAN CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 21. SOUTH KOREA CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 22. REST OF ASIA-PACIFIC CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)
• 23. REST OF THE WORLD CYCLOTRON MARKET SIZE, 2023-2031 ($ MILLION)

Global Cyclotron Market Size, Share & Trends Analysis Report by Product (Cyclotron 10-12MeV, Cyclotron 16-18MeV, Cyclotron 19-24MeV, and Cyclotron above 24MeV), by Application(Medical, and Industrial), Forecast Period (2024-2031)

The global cyclotron market is anticipated to grow at a CAGR of 11.2% during the forecast period (2023-2030).The market growth is attributed to factors such as the growing prevalence of cancer and the increasing use of diagnostic imaging procedures. According to the World Health Organization, cancer is a leading cause of death around the globe, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In terms of new cases of cancer in 2020 included breast (2.26 million cases);lung (2.21 million cases);colon and rectum (1.93 million cases). Several lifestyle factors contribute to the development of cancer such as a high intake of processed meats and low intake of fruits and vegetables, a sedentary lifestyle, obesity, smoking, and excessive alcohol consumption.

Segmental Outlook

The global cyclotron market is segmented on the product and application. Based on the product, the market is sub-segmented into cyclotron 10-12MeV, cyclotrons 16-18MeV, cyclotron 19-24MeV, and cyclotron above 24MeV.Further, based on application, the market is sub-segmented into medical, and industrial. Among the products, the cyclotron 10-12 MeV sub-segment is anticipated to hold a considerable share of the market, owing to the cyclotron 10-12 MeV range being instrumental in the production of radioisotopes used for medical imaging, particularly in positron emission tomography (PET).

Medical Sub-Segment is Anticipated to Hold a Considerable Share of the Global Cyclotron Market

Among the applications, the medical sub-segment is expected to hold a considerable share of the global cyclotron market. The segmental growth is attributed to the increasing use in radiopharmaceutical production in various medical imaging techniques, such as positron emission tomography (PET), and increasing demand in nuclear medicine procedures for accurate disease diagnosis. Nuclear medicine procedures are vital for detecting and monitoring various medical conditions. According to the World Nuclear Association, about 40 million procedures are carried out each year globally with nuclear medicines, with an annual growth rate of 5.0% per annum. Over 10,000 hospitals globally use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m), accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine around the globe.

Regional Outlook

The global cyclotron market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia Pacific is anticipated to exhibit highest CAGR during the forecast period. The advancing medical technologies, rising disposable income, and improving healthcare infrastructure in emerging economies are driving the cyclotron market in the Asia-Pacific.

North America Held Considerable Share in the Global Cyclotrons Market

The rising prevalence of cancer, favorable government initiatives, and highly developed healthcare infrastructure is a key factor driving the regional market. According to the American Cancer Society 'Cancer Facts & Figures 2022', around 1,918,030 new cancer cases and 609,360 mortalities due to cancers are estimated in the US in the year 2022. Such a high incidence of cancers in this region is anticipated to increase the adoption of cyclotrons for the diagnosis of cancer, driving market growth in this region.

Market Players Outlook

The major companies serving the cyclotron market include Siemens Medical Solutions USA, Inc., IBA Radiopharma Solutions, GE HealthCare, Advanced Cyclotron Systems, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, Fusion Pharmaceuticals Inc., and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. entered into a preferred partner agreement for the supply of actinium-225. Under the agreement, BWXT Medical offered predetermined amounts of Fusion's actinium supply needs at volume-based pricing.

The Report Covers:

• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global cyclotron market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Advanced Cyclotron Systems, Inc
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. GE HealthCare Technologies Inc.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Ion Beam Applications SA (IBA)
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Siemens Medical Solutions USA, Inc.
  • 3.5.1. Overview
  • 3.5.2. Financial Analysis
  • 3.5.3. SWOT Analysis
  • 3.5.4. Recent Developments
• 3.6. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global CyclotronMarket by Product
  • 4.1.1. Cyclotron 10-12MeV
  • 4.1.2. Cyclotron 16-18MeV
  • 4.1.3. Cyclotron 19-24MeV
  • 4.1.4. Cyclotron above 24MeV
• 4.2. Global Cyclotron Market by Application
  • 4.2.1. Medical
  • 4.2.2. Industrial

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Alcen
• 6.2. Best Cyclotron Systems, Inc.
• 6.3. Covidien plc
• 6.4. Cyclotron Inc.
• 6.5. IONETIX Corp.
• 6.6. Isosolution Inc.
• 6.7. Nueclear Healthcare Ltd.
• 6.8. Samsung Medical
• 6.9. Stryker Corp.
• 6.10. Sumitomo Heavy Industries, Ltd.
• 6.11. TeamBest
• 6.12. Varian Medical Systems, Inc.